COVID-19 and HIV co-infection: a living systematic evidence map of current research
Masukume, G.; Mapanga, W.; van Zyl, D. S.
Show abstract
The world currently faces two ongoing devastating pandemics. These are the new severe acute respiratory syndrome coronavirus 2/coronavirus disease 2019 (SARS-CoV-2/COVID-19) and the prior human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemics. The literature regarding the confluence of these global plagues expands at pace. A systematic search of the literature considering COVID-19 and HIV co-infection was performed. After five months, from the beginning of the COVID-19 pandemic, there were at least thirty-five studies reported from thirteen countries. These ranged from individual case reports and series to cohort studies. Based on studies that could be extrapolated to the general population, co-infected individuals with suppressed HIV viral loads did not have disproportionate COVID-19 sickness and death. At least four patients, newly diagnosed with HIV recovered from COVID-19. Current evidence suggests that co-infected patients should be treated like the general population. This ongoing living systematic evidence map of contemporary primary SARS-CoV-2 and HIV co-infection research provides a platform for researchers, policy makers, clinicians and others to more quickly discover and build relevant insights.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protocol for the systematic review of the Pneumocystis jirovecii -associated pneumonia in non-HIV immunocompromised patients 93%
- Impact Of The COVID-19 Pandemic On Routine HIV Care And Antiretroviral Treatment Outcomes In Kenya: A Nationally Representative Analysis 92%
- Early clinical characteristics of Covid-19: scoping review 92%
Similar papers in this journal
- The global burden of HIV among Long-distance truck drivers: A systematic review and meta-analysis 93%
- The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review. 92%
- Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials 92%
Similar papers in this journal
- Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan Africa 92%
- Circumcision for HIV prevention in men who have sex with men: an updated meta-analysis 91%
- Interest in and preference for long-acting injectable PrEP among men who have sex with men, trans* individuals, and cis-gender heterosexual women: a global systematic review and meta-analysis 91%
Similar papers in this journal
- Postpartum continuity of care for women with HIV: Option B+ policy impact and limitations in South Africa 92%
- Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis 92%
- Law, Criminalisation and HIV in the World: Have countries that criminalise achieved more or less successful AIDS pandemic response? 91%
Similar papers in this journal
- Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV 92%
- Systematic analysis of electronic health records identifies drugs reducing risk of COVID-19 hospitalization and severity 90%
- Multicenter preclinical studies as an innovative method to enhance translation: a systematic review of published studies 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.